Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1994 1
1996 2
1998 2
1999 1
2000 3
2006 1
2015 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
GLP-1 Cleavage Product Reverses Persistent ROS Generation After Transient Hyperglycemia by Disrupting an ROS-Generating Feedback Loop.
Giacco F, Du X, CarratĂș A, Gerfen GJ, D'Apolito M, Giardino I, Rasola A, Marin O, Divakaruni AS, Murphy AN, Shah MS, Brownlee M. Giacco F, et al. Diabetes. 2015 Sep;64(9):3273-84. doi: 10.2337/db15-0084. Diabetes. 2015. PMID: 26294429 Free PMC article.
Methylglyoxal modification of mSin3A links glycolysis to angiopoietin-2 transcription.
Yao D, Taguchi T, Matsumura T, Pestell R, Edelstein D, Giardino I, Suske G, Ahmed N, Thornalley PJ, Sarthy VP, Hammes HP, Brownlee M. Yao D, et al. Cell. 2006 Jan 27;124(2):275-86. doi: 10.1016/j.cell.2005.11.024. Epub 2006 Jan 12. Cell. 2006. PMID: 16413606 Free article. Retracted.
Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine.
Edelstein D, Brownlee M. Edelstein D, et al. Diabetes. 1992 Jan;41(1):26-9. doi: 10.2337/diab.41.1.26. Diabetes. 1992. PMID: 1727735
Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation.
Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, Brownlee M. Du XL, et al. Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12222-6. doi: 10.1073/pnas.97.22.12222. Proc Natl Acad Sci U S A. 2000. PMID: 11050244 Free PMC article.
Hyperinsulinemia enhances transcriptional activity of nuclear factor-kappaB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells.
Golovchenko I, Goalstone ML, Watson P, Brownlee M, Draznin B. Golovchenko I, et al. Circ Res. 2000 Oct 27;87(9):746-52. doi: 10.1161/01.res.87.9.746. Circ Res. 2000. PMID: 11055977
Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization.
Hammes HP, Brownlee M, Jonczyk A, Sutter A, Preissner KT. Hammes HP, et al. Nat Med. 1996 May;2(5):529-33. doi: 10.1038/nm0596-529. Nat Med. 1996. PMID: 8616710
Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis.
Giardino I, Fard AK, Hatchell DL, Brownlee M. Giardino I, et al. Diabetes. 1998 Jul;47(7):1114-20. doi: 10.2337/diabetes.47.7.1114. Diabetes. 1998. PMID: 9648836
Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations.
Hammes HP, Brownlee M, Lin J, Schleicher E, Bretzel RG. Hammes HP, et al. Diabetologia. 1999 May;42(5):603-7. doi: 10.1007/s001250051201. Diabetologia. 1999. PMID: 10333054
BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells.
Giardino I, Edelstein D, Brownlee M. Giardino I, et al. J Clin Invest. 1996 Mar 15;97(6):1422-8. doi: 10.1172/JCI118563. J Clin Invest. 1996. PMID: 8617874 Free PMC article.
Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes.
Giardino I, Edelstein D, Brownlee M. Giardino I, et al. J Clin Invest. 1994 Jul;94(1):110-7. doi: 10.1172/JCI117296. J Clin Invest. 1994. PMID: 8040253 Free PMC article.
13 results
Jump to page